Legend Biotech (LEGN) Net Income towards Common Stockholders Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) Net Income towards Common Stockholders Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -58.11% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 104.24% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -290.15% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.24% |
| Sep 30, 2025 | 69.31% |
| Jun 30, 2025 | 37.62% |
| Mar 31, 2025 | -68.78% |
| Dec 31, 2024 | 33.37% |
| Sep 30, 2024 | -101.46% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 46.66% |
| Dec 31, 2023 | 34.83% |
| Sep 30, 2023 | 26.78% |
| Jun 30, 2023 | -3.05% |
| Mar 31, 2023 | -247.18% |
| Dec 31, 2022 | -53.82% |
| Sep 30, 2022 | 31.90% |
| Jun 30, 2022 | -110.98% |
| Mar 31, 2022 | -35,570.18% |
| Dec 31, 2021 | -52.76% |
| Sep 30, 2021 | -87.47% |
| Jun 30, 2021 | 32.10% |
| Mar 31, 2021 | 99.80% |